These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 16715364)
1. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. Lopes LB; Ferreira DA; de Paula D; Garcia MT; Thomazini JA; Fantini MC; Bentley MV Pharm Res; 2006 Jun; 23(6):1332-42. PubMed ID: 16715364 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systems. Lopes LB; Speretta FF; Bentley MV Eur J Pharm Sci; 2007 Nov; 32(3):209-15. PubMed ID: 17900879 [TBL] [Abstract][Full Text] [Related]
3. Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery. Lopes LB; Lopes JL; Oliveira DC; Thomazini JA; Garcia MT; Fantini MC; Collett JH; Bentley MV Eur J Pharm Biopharm; 2006 Jun; 63(2):146-55. PubMed ID: 16621488 [TBL] [Abstract][Full Text] [Related]
4. Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: Nanodispersions of liquid-crystalline phase as nanocarriers. Rossetti FC; Depieri LV; Praça FG; Del Ciampo JO; Fantini MC; Pierre MB; Tedesco AC; Bentley MV Eur J Pharm Sci; 2016 Feb; 83():99-108. PubMed ID: 26657201 [TBL] [Abstract][Full Text] [Related]
5. Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer. Lopes LB; Collett JH; Bentley MV Eur J Pharm Biopharm; 2005 May; 60(1):25-30. PubMed ID: 15848052 [TBL] [Abstract][Full Text] [Related]
6. Effect of vehicles and enhancers on the topical delivery of cyclosporin A. Liu H; Li S; Wang Y; Yao H; Zhang Y Int J Pharm; 2006 Mar; 311(1-2):182-6. PubMed ID: 16439077 [TBL] [Abstract][Full Text] [Related]
7. Analysis of liquid crystalline nanoparticles by small angle X-ray diffraction: evaluation of drug and pharmaceutical additives influence on the internal structure. Rossetti FC; Fantini MC; Carollo AR; Tedesco AC; Bentley MV J Pharm Sci; 2011 Jul; 100(7):2849-57. PubMed ID: 21337546 [TBL] [Abstract][Full Text] [Related]
9. Liquid Crystalline Nanodispersions Functionalized with Cell-Penetrating Peptides for Topical Delivery of Short-Interfering RNAs: A Proposal for Silencing a Pro-Inflammatory Cytokine in Cutaneous Diseases. Petrilli R; Eloy JO; Praça FS; Del Ciampo JO; Fantini MA; Fonseca MJ; Bentley MV J Biomed Nanotechnol; 2016 May; 12(5):1063-75. PubMed ID: 27305826 [TBL] [Abstract][Full Text] [Related]
10. Monoolein liquid crystalline phases for topical delivery of crocetin. Esposito E; Carducci F; Mariani P; Huang N; Simelière F; Cortesi R; Romeo G; Puglia C Colloids Surf B Biointerfaces; 2018 Nov; 171():67-74. PubMed ID: 30015140 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of the skin penetration of protein transduction domains and a conjugated peptide. Lopes LB; Brophy CM; Furnish E; Flynn CR; Sparks O; Komalavilas P; Joshi L; Panitch A; Bentley MV Pharm Res; 2005 May; 22(5):750-7. PubMed ID: 15906170 [TBL] [Abstract][Full Text] [Related]
12. Development of microemulsions of suitable viscosity for cyclosporine skin delivery. Benigni M; Pescina S; Grimaudo MA; Padula C; Santi P; Nicoli S Int J Pharm; 2018 Jul; 545(1-2):197-205. PubMed ID: 29698819 [TBL] [Abstract][Full Text] [Related]
13. Liquid Crystalline Systems Based on Glyceryl Monooleate and Penetration Enhancers for Skin Delivery of Celecoxib: Characterization, In Vitro Drug Release, and In Vivo Studies. Dante MCL; Borgheti-Cardoso LN; Fantini MCA; Praça FSG; Medina WSG; Pierre MBR; Lara MG J Pharm Sci; 2018 Mar; 107(3):870-878. PubMed ID: 29108729 [TBL] [Abstract][Full Text] [Related]
14. Influence of internal structure and composition of liquid crystalline phases on topical delivery of paclitaxel. Hosmer JM; Shin SH; Nornoo A; Zheng H; Lopes LB J Pharm Sci; 2011 Apr; 100(4):1444-55. PubMed ID: 20957759 [TBL] [Abstract][Full Text] [Related]
15. A delivery system to avoid self-aggregation and to improve in vitro and in vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy. Rossetti FC; Lopes LB; Carollo AR; Thomazini JA; Tedesco AC; Bentley MV J Control Release; 2011 Nov; 155(3):400-8. PubMed ID: 21763732 [TBL] [Abstract][Full Text] [Related]
16. Curcumin containing monoolein aqueous dispersions: a preformulative study. Esposito E; Ravani L; Mariani P; Contado C; Drechsler M; Puglia C; Cortesi R Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4923-34. PubMed ID: 24094206 [TBL] [Abstract][Full Text] [Related]
17. Hexagonal Liquid Crystalline Nanodispersions Proven Superiority for Enhanced Oral Delivery of Rosuvastatin: In Vitro Characterization and In Vivo Pharmacokinetic Study. Gabr MM; Mortada SM; Sallam MA J Pharm Sci; 2017 Oct; 106(10):3103-3112. PubMed ID: 28479357 [TBL] [Abstract][Full Text] [Related]
18. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation. Kim ST; Jang DJ; Kim JH; Park JY; Lim JS; Lee SY; Lee KM; Lim SJ; Kim CK Pharmazie; 2009 Aug; 64(8):510-4. PubMed ID: 19746839 [TBL] [Abstract][Full Text] [Related]
19. Cutaneous penetration of soft nanoparticles via photodamaged skin: Lipid-based and polymer-based nanocarriers for drug delivery. Hung CF; Chen WY; Hsu CY; Aljuffali IA; Shih HC; Fang JY Eur J Pharm Biopharm; 2015 Aug; 94():94-105. PubMed ID: 25986584 [TBL] [Abstract][Full Text] [Related]
20. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase. Depieri LV; Borgheti-Cardoso LN; Campos PM; Otaguiri KK; Vicentini FT; Lopes LB; Fonseca MJ; Bentley MV Eur J Pharm Biopharm; 2016 Aug; 105():50-8. PubMed ID: 27224855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]